About Iaso Therapeutics
Iaso Therapeutics is a private company based in East Lansing, Michigan. It has reported $1,007,850 raised in two offerings on Form D since January 2023. Its chief executive is Robert Forgey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Jan 14, 2026 | $570,000of $1.8M target | 1 | $570K | OptionsRule 506(b) | Form D ↗ |
| Dec 22, 2022 | Jan 6, 2023 | $437,850of $1.3M target | 5 | $87,570 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,007,850 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Iaso Therapeutics's Form D filed Jan 14, 2026.
SK
Steve Kuemmerie
Director
RF
Robert Forgey
President and CEO, director
XH
Xuefei Huang
Executive officer and director
DP
Donald Parfet
Director
JW
Jeffrey Wesley
Director
Earlier filings also listed Herbert Kavunja (executive officer, last listed Jan 2023).